Evidence map›Paper›PMID 40900832›Full record

ArticleFrontiers in pharmacology2025

Qiancao (

Mingtong Zhang, Junyan Du, Donghua Li, Xiao Ma, Wanjun Jin, Lei Xiang, Meng Wen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mingtong Zhang *Gansu Provincial Engineering Laboratory of Chinese and Tibetan Medicine Inspection and Testing, State Key Laboratory for Quality Control of Chinese Medicinal Materials and Decoction Pieces, Gansu Institute for Drug Control, Lanzhou, China.
Junyan Du *Department of Health, Lanzhou Modern Vocational College, Lanzhou, China.
Donghua LiGansu Provincial Engineering Laboratory of Chinese and Tibetan Medicine Inspection and Testing, State Key Laboratory for Quality Control of Chinese Medicinal Materials and Decoction Pieces, Gansu Institute for Drug Control, Lanzhou, China.
Xiao MaGansu Provincial Engineering Laboratory of Chinese and Tibetan Medicine Inspection and Testing, State Key Laboratory for Quality Control of Chinese Medicinal Materials and Decoction Pieces, Gansu Institute for Drug Control, Lanzhou, China.
Wanjun JinGansu Provincial Engineering Laboratory of Chinese and Tibetan Medicine Inspection and Testing, State Key Laboratory for Quality Control of Chinese Medicinal Materials and Decoction Pieces, Gansu Institute for Drug Control, Lanzhou, China.
Lei XiangDepartment of Inpatient Pharmacy, Affiliated Hospital of Chifeng University, Chifeng, China.
Meng WenDepartment of Nursing, Gansu Health Vocational College, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Qiancao comprises five closely related species: Methods: This study employed a metabolomics approach to investigate the five Results and discussion: This metabolomics analysis identified a total of 1,440 metabolites. Comparative analyses revealed significant differences in the metabolic profiles among the five species. Specifically, we detected 237, 217, 448, and 226 differentially accumulated metabolites when comparing

Indexed as

differential accumulated metabolitesdifferent speciesdiscriminationmetabolomicsqiancao

Identifiers

PMID40900832
PMCPMC12399549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.